in_pic.jpg

Contact

captcha

Renova in Shanghai, China

A Renova 2-day event was successfully conducted in Shanghai where the Renova product, protocol and clinical successes were presented to 50 local and provincial dealers active in the field of sexual medicine and urology. Chinese FDA approval is expected during Q1/ 2017, following a successful multi-site randomized clinical study that further demonstrates Renova's clinical benefit –the unique Linear Shockwave technology.

The expected CFDA approval for Renova follows similar regulatory approvals achieved to-date in Europe, Russia, Australia, Brazil, Mexico and others.

 

About DirexGroup:
DirexGroup specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established over 30 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assures competent support and maintenance. Contact DirexGroup at: This email address is being protected from spambots. You need JavaScript enabled to view it.

Off Canvas Menu